Nuclear factor-KB (NF-KB) activation has been shown to be both antiapoptotic and proapoptotic depending on the stimulus and the specific cell type involved. NF-KB activation has also been shown to be essential for apoptosis induction by a number of agents. The novel retinoid-related molecule 4-[3-Cl-
Introduction
The Rel/nuclear factor-nB (NF-nB) family of eukaryotic transcription factors is composed of a number of structurally related proteins that form homodimers and heterodimers (1) . In vertebrates, the Rel/NF-nB family includes p50/p105, p52, p100, RelA (p65), c-Rel, and Rel B (2) . These dimers are sequestered in the cytoplasm bound to InBa. Upon the appropriate stimulation, InBa is phosphorylated by the IKKa or IKKh kinase at specific serines, which then allows InBa to undergo proteolysis through the proteosome pathway with the subsequent NF-nB translocation to the nucleus (3) . These dimers then bind to specific DNA consensus sequences in promoters and thus regulate the expression of a number of genes. Numerous stimuli have been shown to activate NF-nB. NF-nB has been found to play both an antiapoptotic role and proapoptotic role depending on the stimuli utilized and the cell type involved (4) . The antiapoptotic effects of NF-nB have been shown in a number of investigations. Knockout of RelA results in an embryonic lethal phenotype in transgenic mice because of the failure of RelA to inhibit tumor necrosis factor (TNF) apoptosis of hepatocytes (5, 6) . In addition, NF-nB inhibits TNF-mediated apoptosis in Jurkat T cells, primary rat and human fibroblasts, and in MCF-7 breast carcinoma cell lines (7, 8) . NF-nB has also been shown to protect against chemotherapy-mediated apoptosis in a number of malignant cell lines (9) .
Recent observations have implicated NF-nB activation in the induction of apoptosis (10) (11) (12) . More importantly, with the development of inhibitors of NF-nB, more definite evidence has been generated documenting a role for NF-nB in the induction of apoptosis in a number of systems (13, 14) . Studies have shown that etoposide-induced apoptosis in leukemic cells requires NF-nB activation and that inhibition of NF-nB activation prevents etoposide induction of apoptosis in these cells (15) . Recent investigations have implicated that this paradoxical effect of NF-nB on apoptosis is dependent on the stimulus and cell type as well as which of the NF-nB family members is activated (16) . It has been speculated that c-Rel and RelA function as mediators of proapoptotic and antiapoptotic signaling, respectively (ref. 16 and references within). However, other investigators have suggested that both c-Rel and RelA can function as proapoptotic agents (17) (18) (19) .
We previously reported that exposure of cells to the novel compound 4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC), which binds to the retinoic acid receptor g (RARg) but does not activate it, results in apoptosis in cells in vitro as well as in an acute myelogenous leukemia mouse model with minimal toxicity (20, 21) . In addition, we found that exposure to 3-Cl-AHPC activated the expression of a number of genes that have NF-nB consensus sequences in their promoters. In this report, we show that 3-Cl-AHPC activates the p65 subunit of NF-nB and that p65 activation is necessary for 3-Cl-AHPCmediated apoptosis.
Materials and Methods
Materials/antibodies. 3-Cl-AHPC was synthesized as described previously (20, 21) and stored at À80jC in DMSO. DMEM-F12 medium, fetal bovine serum, Trizol reagent, and neomycin were purchased from Invitrogen, Inc. (Grand Island, NY). Anti-InBa, anti-heat shock protein HSP90, anti-IKKa, anti-IKKh, and anti-receptor interacting protein (RIP) antibodies were from Cell Signaling (Beverly, MA). Anti-Fas antibody was from BD Transduction Laboratories (San Diego, CA). Anti-X-linked inhibitor of apoptosis protein (XIAP) and anti-c-IAP1 antibodies were from R&D Systems (Minneapolis, MN); anti-Bcl-X L , anti-c-IAP2, and HSP90h were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); and anti-Trail-R1 (DR4) and anti-Trail-R2 (DR-5) antibodies were from Axxora, LLC (San Diego, CA). a-Tubulin antibody was from Oncogene Research Products (Boston, MA), helenalin from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA), and geldanamycin from NIH (Bethesda, MD).
Cell culture and apoptosis. The human prostate carcinoma cell lines, DU145, LNCaP, and PC-3, and the breast carcinoma cell line, MDA-MB-468, were maintained in DMEM-F12 medium as described (22) . Mouse embryonic fibroblasts (MEF) derived from RelA-deficient mice fibroblast and 3T3 p65À/À and wild-type 3T3 fibroblasts were provided by Dr. Amer Beg (Department of Biological Sciences, Columbia University, New York, NY) (6) . Apoptosis of cells was assessed either using acridine orange staining as previously described (22) or using Apoptosis ELISA kits obtained from Roche Diagnostic Laboratory (Indianapolis, IN). The assay was done as described in ref. (22) .
Transfection and luciferase assay. For reporter gene assay, DU145 and MDA-MB-468 cells were seeded into 1 Â 10 6 cells per Petri dish (100 Â 20 mm) and transfected with 10 Ag NF-nB-driven reporter (luciferase) gene construct by the calcium phosphate precipitation method (23); 36 hours following transfection, cells were treated with 1 Amol/L 3-Cl-AHPC, the proteasome inhibitor N-acetyl-L-leucinyl-L-leucinyl-norleucinal (LLnL; 50 Amol/L; Sigma, St. Louis, MO), and combination of both for 24 hours. Cells were harvested and reporter gene activity determined utilizing a luciferase assay. A h-galactosidase expression vector was used to normalize transfection efficiencies. InB dominant negative-expressing cells, DU145 and MDA-MB-468 cells, were stably transfected with 8.0 Ag of the vector pUSE and double mutant (S32A, S36A) InBDN-pUSE plasmids (Upstate Biotechnology, Lake Placid, NY) per plate using LipofectAMINE Plus (Invitrogen, Carlsbad, CA) and the protocol provided by the manufacturer; 36 hours following the transfection, the cells were treated with 400 and 600 Ag/mL neomycin, respectively, for selection of stable DU145 and MDA-MB-468 InB dominant negative-expressing cell lines.
Western blots. Cells were lysed following incubation in lysis buffer [50 mmol/L Tris (pH 7.5), 100 mmol/L NaCl, 1 mmol/L EDTA, 0.5% NP40, 0.5% Triton X-100, 2.5 mmol/L sodium orthovanadate, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 10 AL/mL protease inhibitor cocktail; Sigma, St. Louis, MO] for 20 minutes at 4jC. Protein concentration was determined using the Bio-Rad assay system (Bio-Rad, Hercules, CA). Total proteins were fractionated using SDS-PAGE and transferred onto nitrocellulose membrane. The membranes were blocked with 5% nonfat dried milk in 1Â TBS buffer containing 0.1% Tween 20 and then incubated with appropriate primary antibody. Horseradish peroxidase-conjugated antirabbit or antimouse IgG was used as the secondary antibody (Amersham Pharmacia Biotech, Piscataway, NJ) and the protein bands were developed using the enhanced chemiluminesence detection system (Amersham Pharmacia Biotech).
Immunoprecipitation studies. Total protein (1 mg) was incubated with 1 Ag of appropriate antibody and 20 AL of Protein G Sepharose 4 Fast Flow bead (Amersham Pharmacia Biotech) overnight at 4jC, centrifuged, and washed thrice with TT buffer [50 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, and 0.5% Tween 20] and twice with lysis buffer. Proteins were eluted with Laemmli sample buffer and fractionated using SDS-PAGE as described for Western blots. Coimmunoprecipitations were done as we have previously described (24) .
IKB kinase assay. MDA-MB-468 and DU145 cells were treated with 1 Amol/L 3-Cl-AHPC for various times and lysed in a lysis buffer containing 50 mmol/L Tris (pH 8.0), 500 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA (pH 8.0), 10 mmol/L h-glycerophosphate, 10 mmol/L NaF, 10 mmol/L, p-nitro-phenyl phosphate, 300 Amol/L sodium orthovanadate, 1 mmol/L DTT, 0.1% NP40, 0.5 mmol/L PMSF, and 10 AL/mL protease inhibitor cocktail. Cell lysates were immunoprecipitated using anti-IKKa and IKKh polyclonal antibodies and incubated with Protein G Sepharose 4 Fast Flow beads for overnight. The immunocomplexes were washed twice with lysis buffer and with kinase buffer [20 mmol/L HEPES (pH 7.5), 2 mmol/L MgCl 2 , 10 mmol/L h-glycerophosphate, 10 mmol/L NaF, 10 mmol/L p-nitro-phenyl phosphate, 300 Amol/L sodium orthovanadate, 1 mmol/L DTT, 5 AL/mL protease inhibitor cocktail, and 10 Amol/L ATP]. The kinase reaction was done using an InBa glutathione S-transferase fusion protein (Santa Cruz Biotechnology) as a substrate (2.5 Ag) in the presence of 10 ACi per reaction [g-32 P]ATP (Amersham Pharmacia Biotech). The reaction was incubated for 45 minutes at 30jC, stopped with Laemmli sample buffer, and analyzed following fractionation of the proteins by 10% SDS-PAGE by autoradiography.
Gel shift analysis. Nuclear NF-nB was assessed by the electrophoretic gel mobility shift assay using NF-nB/Rel Family Nushift kit purchased from Geneka Biotechnology, Inc. (Quebec, Canada). The assay was done according to either the manufacturer's instructions and as described previously (23) . Nuclear extracts were prepared as described in ref. (23) . Nuclear extracts (10 Ag) were incubated with 1 AL of [g-32 P]ATP-labeled NF-nB oligonucleotide (5,000 cpm) in 20 AL of binding buffer. The specificity of NF-nB DNA-binding activity was confirmed by competition with excess cold wild-type NF-nB consensus sequence or mutant NF-nB oligonucleotide (Santa Cruz Biotechnology). To identify the subunit components of activated NF-nB complexes, supershift analyses were done by additional 30-minute incubations at 4jC with polyclonal supershift antibodies against p65, p50, or c-Rel before the addition of labeled probe. DNA-protein complexes were resolved by electrophoresis in 5% nondenaturing polyacrylamide gels and analyzed by autoradiography.
RNase protection assay. MDA-MB-468 and DU145 cells were treated with 1 Amol/L 3-Cl-AHPC for 6 and 24 hours and total RNAs were extracted using Trizol reagent. Probe synthesis, RNA preparation and hybridization, RNase treatments, and gel preparation were done per the manufacturer's suggestion (PharMingen, San Diego, CA). Twenty micrograms of RNA were used for each sample and incubated with [a-
32 P]UTP-labeled singlestranded RNA probes overnight at 56jC. The RNA-RNA complexes were resolved by electrophoresis in 5% denaturing polyacrylamide gels and autoradiography was done.
Results

4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic
acid exposure results in nuclear factor-KB activation. Exposure to 3-Cl-AHPC results in NF-nB activation (Fig. 1A) . MDA-MB-468 and DU145 cells were transfected with a NF-nB reporter construct and the cells then exposed to 3-Cl-AHPC. A 2-to 3-fold increase in NF-nB activation was noted (Fig. 1A) . NF-nB activation requires InBa degradation, which occurs through the proteasome pathway (3, (25) (26) (27) (28) . We, therefore, determined whether exposure to 3-Cl-AHPC results in a decrease in InBa levels and whether inhibition of the proteasome pathway inhibits 3-Cl-AHPC-mediated NF-nB activation, 3-Cl-AHPC-mediated decrease in InBa levels, and 3-Cl-AHPC-mediated apoptosis. Decrease in InBa levels was noted in all four cell lines within 24 hours following 3-Cl-AHPC exposure (Fig. 1B) . We found that the proteasome inhibitor LLnL blocked not only 3-Cl-AHPC-mediated NF-nB activation and decrease in InBa levels but 3-Cl-AHPC-mediated apoptosis as well, suggesting that NF-nB activation is required for 3-Cl-AHPC induction of apoptosis (Fig. 1A-D) .
IKBA dominant negative inhibits 3-Cl-AHPC-mediated apoptosis. The dominant-negative InBa reporter construct in which Ser 32 and Ser 36 have been mutated to alanine is resistant to phosphorylation by the IKKs; this, in turn, prevents InBa degradation through the proteasome pathway and subsequent NF-nB activation (29) (30) (31) . Utilizing this strategy, we found that expression of the InBa dominant negative in both DU145 and MDA-MB-468 cells resulted in the inhibition of 3-Cl-AHPCmediated degradation of InBa ( Fig. 2A) as well as significant inhibition of 3-Cl-AHPC induction of apoptosis but increased the basal apoptotic rate in both cell lines (Fig. 2B) .
4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid activates IKB kinase A. Phosphorylation of InBa and InBh at specific serine residues with subsequent degradation of these molecules and NF-nB activation can be achieved through activation of the InB kinase IKK (26) (27) (28) 32) . IKK is a complex consisting of at least three different protein kinases, IKKa, IKKh, and IKKg (28) . The ability of 3-Cl-AHPC to activate IKKa and IKKh was examined. Cells were exposed to 3-Cl-AHPC for various times and IKK activation was assessed. Activation of IKKa but not IKKh was observed within 24 hours of 3-Cl-AHPC exposure in both DU145 and MDA-MB-468 cells (Fig. 3A and B) . A requirement for HSP90 for NF-nB activation has been suggested by several studies (33) . In addition, other investigators have suggested that the interaction between HSP90 and IKKa and IKKh enhances IKK constitutive and inducible activity resulting in NF-nB activation (34) . We had previously found that 3-Cl-AHPC exposure results in increased HSP90h levels. We, therefore, examined whether exposure of DU145 and MDA-MB-468 cells to 3-Cl-AHPC results in enhanced association between IKKa and HSP90h. Incubation of DU145 and MDA-MB-468 cells with 3-Cl-AHPC for even 6 hours resulted in the enhanced association between IKKa and HSP90h ( Fig. 3C and D) . Incubation of cells with the specific HSP90 inhibitor geldanamycin has been shown to inhibit lipopolysaccharide and taxol-induced NF-nB activity and mitogen-induced NF-nB activity in spleen cells (35) (36) (37) . Incubation of DU145 and MDA-MB-468 cells with geldanamycin resulted in the degradation IKKa and blocked constitutive NF-nB activity as well as 3-Cl-AHPC-mediated NF-nB activation and apoptosis ( Fig. 3E-G) .
Treatment with 4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid results in activation of the p65 nuclear factor-KB subunit. We next did gel mobility shift assays to Research.
on July 27, 2017. © 2005 American Association for Cancer cancerres.aacrjournals.org Downloaded from further confirm 3-Cl-AHPC-mediated NF-nB activation and identify which of the NF-nB subunits were involved (Fig. 4A) . Cells were incubated with 3-Cl-AHPC or vehicle for 24 hours and nuclear extracts prepared. Exposure to 3-Cl-AHPC resulted in NF-nB activation as evidenced in lane 5 by the increased binding of the extracts obtained from the 3-Cl-AHPC-exposed cells to the NF-nB consensus sequence. That this binding indeed represented NF-nB subunit binding to the labeled consensus sequence is confirmed by the fact that it was totally eliminated by the addition of excess unlabeled NF-nB consensus sequence but not by an excess of unlabeled mutant oligonucleotide (Fig.  4A, lanes 3, 4 and 6, 7) . Supershift experiments were done to identify the activated NF-nB subunit(s). The addition of specific NF-nB p65 antibody resulted in a supershift ( Fig. 4A; lanes 9 and  12) as did the addition of NF-nB p50 antibody ( Fig. 4A; lanes 10  and 13) . No shift in the bands were noted when c-Rel antibody was added (data not shown). These results indicate that 3-Cl-AHPC exposure resulted in the specific activation of the NF-nB p65 subunit.
p65 expression and activation is necessary for 4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid-mediated apoptosis. To further confirm a role for the p65 subunit in 3-Cl-AHPC-mediated apoptosis, we used the sesquiterpene lactone helenalin, which covalently binds to the NF-nB p65 subunit and thus inhibits NF-nB activation (38) . Incubation of cells in the presence of helenalin resulted in the inhibition of 3-Cl-AHPCmediated apoptosis (Fig. 4B) . This result suggested a proapoptotic role for NF-nB in 3-Cl-AHPC-mediated apoptosis and a role for the p65 subunit. To further document a role for the NF-nB p65 subunit, the ability of 3-Cl-AHPC to induce apoptosis in wild-type and p65À/À MEFs was examined (Fig. 4C) . Loss of p65 expression completely inhibited 3-Cl-AHPC-mediated apoptosis, further Figure 3 . Exposure to 3-Cl-AHPC results in enhanced IKKa activity and the association between IKKa and HSP90h. Cells were exposed to 1 Amol/L 3-Cl-AHPC for varying times. A, exposure to 3-Cl-AHPC results in enhanced IKKa activity. IKKa and IKKh activities were determined as described in Materials and Methods. B, quantitation of IKKa activities. C, association between IKKa and HSP90h was assessed using immunoprecipitation and Western blots. D, quantitation of IKKa associated with HSP90 and HSP90h protein levels. E, geldanamycin decreases IKKa levels. F, inhibition of 3-Cl-AHPC-mediated NF-nB activation. G, inhibition of AHPC-mediated apoptosis. Cells were treated with either vehicle or 1 Amol/L 3-Cl-AHPC and in the presence or absence of 1 Amol/L geldanamycin for 24 hours in cells transfected with a NF-nB reporter construct as described in the legend of Fig. 1 . NF-nB activation was assessed as described in Materials and Methods. Apoptosis was assessed using acridine orange staining as described in Materials and Methods. *Significantly greater than geldanamycin and combination of geldanamycin and 3-Cl-AHPC-treated cells (P < 0.001). substantiating a role for p65 in 3-Cl-AHPC-mediated apoptosis (Fig. 4C) .
Cancer Research
4-[3-Cl-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid inhibits NF-KB induction of X-linked inhibitor of apoptosis protein and Bcl-X L . Numerous investigators have
shown that NF-nB-mediated antiapoptotic effects are at least partially explained by NF-nB induction of c-IAP1, c-IAP2, XIAP, and Bcl-X L (17, 39) . We have previously shown that exposure of cells to 3-Cl-AHPC results in the cleavage of Bcl-X L and the generation of a proapoptotic molecule in leukemia cells (20, 21) . We investigated the effect of 3-Cl-AHPC on c-IAP1, c-IAP2, XIAP, and Bcl-X L in the MDA-MB-468 and DU145 cells. Incubation with 3-Cl-AHPC resulted in a marked decrease in Bcl-X L , c-IAP1, and XIAP expression but had no effect on or c-IAP2 expression (Fig. 5A  and B) . Loss of expression of the NF-nB p65 subunit prevented 3-Cl-AHPC-mediated decrease in XIAP levels, suggesting that p65 expression is required (Fig. 5C ).
4-[3-Cl-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid induction of Fas, DR4, and DR5 expression. The ability of NF-nB to induce the expression of over 150 proteins has been documented (2) . Whereas a number of these proteins seem to have antiapoptotic effects, NF-nB has also been shown to induce the expression of a number of proapoptotic proteins, including Fas, Fas ligand, and the death receptors DR4 and DR5 (4, 16, 18) . Therefore, we assessed whether 3-Cl-AHPC exposure results in the induction of these proapoptotic proteins and if NF-nB activation is involved. 3-Cl-AHPC exposure indeed enhanced the expression of Fas, DR4, and DR5 mRNA levels as well as the proapoptotic Fas/TNFa-related RIP mRNA levels in the MDA-MB-468 and DU145 cells (Fig. 6A) , but had no effect on caspase 8, TNFRp55, L32 and glyceraldehyde-3-phosphate dehydrogenase mRNA levels (Fig. 6A) . Incubation with 3-Cl-AHPC increased the expression of Fas, DR4, and DR5 protein levels in MDA-MB-468 cells and DUI45 cells but enhanced the expression of RIP protein only in MDA-MB-468 cells (Fig. 6B) . 3-Cl-AHPC had no effect on Fas ligand expression in either cell lines (data not shown). Expression of the InBa dominant negative inhibited the 3-Cl-AHPC-mediated increase in the DR4 and DR5 levels, indicating that NFn-B activation is required (Fig. 6C) .
Discussion
The abilities of NF-nB to suppress cell death have been shown in a variety of systems (5-8, 40, 41) . Activation of NF-nB by TNFa and numerous other stimuli has been shown to be necessary to protect the cells from the apoptosis cascade induced by these molecules (5, 6, 9, 42, 43) . NF-nB suppression of apoptosis seems to be dependent on transcription because inhibitors of transcription as well as translation block the ability of this transcription factor to prevent cell death (6, 44) . NF-nB-mediated induction of the expression of a number of proteins has been associated with apoptosis inhibition. These proteins include the cellular inhibitors of apoptosis (c-IAP), caspase 8-c-FLIP (Flice) inhibitor protein, the Bcl-2 family member BFL-1 (also known as AI), TNF receptorassociated factor-1 (TRAF1) and (TRAF2) and X1AP (45) . These proteins inhibit apoptosis at multiple steps. Studies have shown that many of these factors inhibit the caspase cascade. The c-IAPs have been shown to directly bind and inhibit cellular caspases, such as caspase-3 and caspase-7, and also block the activation of procaspase-6 (46). Several investigators have suggested that c-IAP1 and c-IAP2 can also be recruited to TNFR1 signaling complex Figure 4 . Exposure to 3-Cl-AHPC results in NF-nB p65 and p50 activation, which is required for 3-Cl-AHPC-mediated apoptosis. Cells were exposed to 1 Amol/L 3-Cl-AHPC for 24 hours. A, gel mobility shift assay demonstrating p65 and p50 activation. Left arrows, positions of p65 and p50 subunits. Right arrow, supershifted p65 band. B, quantification of helenalin inhibition of 3-Cl-AHPC induction of apoptosis. C, 3-Cl-AHPC induction of apoptosis in wild-type and p65À/À MEF cells. Apoptosis was assessed using an Apoptosis ELISA kit or acridine orange staining as described in Materials and Methods. B and C, columns, mean of three independent experiments; bars, SE. Research.
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NF-nB enhanced expression of XIAP also contributes to NF-nB inhibition of caspase activity (48) . XIAP has been shown to inhibit caspase-3 and caspase-7 through its IAP repeat (Bir) domain; in addition, this molecule has been shown to inhibit procaspase-9 activation through its Bir 3 domain (49, 50) . We have found that exposure of cells to 3-Cl-AHPC results in activation of the p65 NF-nB subunit but decreased XIAP and c-IAP1 expression, thus inhibiting the ability of these molecules to block NF-nB activation of a proapoptotic pathway. In addition, the 3-Cl-AHPC-mediated decrease in XIAP levels seems to be dependent on NF-nB activation. NF-nB can also induce the expression of proteins that exert their antiapoptotic role via the mitochondrial-dependent pathway (45); these include the factors Bfl-1 and Bcl-X L that inhibit apoptosis-mediated mitochondria depolarization (40) . However, 3-Cl-AHPC exposure inhibits Bcl-X L expression despite NF-nB activation.
Although the vast majority of reports have documented NF-nB as an antiapoptotic molecule, numerous studies are now emerging demonstrating the role of NF-nB in the induction of apoptosis (16) (17) (18) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) . A proapoptotic role for NF-nB has been shown in etoposideinduced apoptosis in human leukemia cell lines, dopamine-induced apoptosis in human breast carcinoma, and human epidermal cells as well as phorbol ester induction of apoptosis in T-cell hybridomas (4, 15, 46) . NF-nB activates the transcription of vast number of genes, some of which encode for proteins that function as inducers of apoptosis (4, 15, 51) . NF-nB enhances the expression of Fas, Fas ligand, and the death receptors DR4 and DR5, all of which play a role in this induction of apoptosis (4, 18) . We have found that 3-Cl-AHPC enhances the expression of Fas as well as the DR4 and the DR5 death receptors and that expression of the InBa dominant negative blocks this induction. Sun et al. (57) have previously shown that the retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437/AHPN) can enhance the expression of DR4 and DR5 in prostate carcinoma cells.
Activation of specific NF-nB subunits is necessary for the enhanced expression of these proapoptotic agents. Chen et al. (16) have found that in human breast carcinoma cells, activation of the NF-nB c-Rel subunit is essential for the enhanced expression of the DR4 and DR5 death receptors in these cells, and the induction of apoptosis and that the activation of p65 results in inhibition of DR4 and DR5 expression as well as tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis. Ouaaz et al. (18) , however, have found that p65 activation is necessary for the enhanced expression of the Fas death receptor. We have found that 3-Cl-AHPC activation of the NF-nB p65 subunit plays an essential role in 3-Cl-AHPC-mediated apoptosis. catalytic subunits and IKKg serves a regulatory role. Activation of IKKa and IKKh is a complex process requiring the dimerization of IKKa and IKKh through their leucine zipper motifs followed by their association with IKKg and the formation of a large complex (58) (59) (60) (61) . Stimulus-mediated activation of the IKK complex seems to require the IKKg carboxyl terminus (59) . Activation of the IKKa-IKKh-IKKg complex also requires the phosphorylation of IKKa or IKKh at two conserved serines (62) . Recent studies have shown that IKKa and IKKh are not redundant (ref. 28 and references within). IKKh activation is required for IKK activation by a number of proinflammatory stimuli, whereas IKKa is essential for IKK activation by a set of signals that do not affect the IKKh subunit (28) . In addition, not only do different stimuli activate IKKa and IKKh, but their biological effects seem to be tissue type specific (28) . We have found that exposure of breast and prostrate carcinoma cells to 3-Cl-AHPC activate IKKa with no effect on IKKh. The exact mechanism involved is not clear. However, we found that 3-Cl-AHPC enhances the association between IKKa and HSP90h, which has been reported to enhance IKK activity (34) . That this association plays a role in 3-Cl-AHPC activation of NF-nB is supported by our observation that the HSP90-specific inhibitor geldanamycin results in decreased IKKa and inhibited both 3-Cl-AHPC-mediated NF-nB activation and induction of apoptosis. Geldanamycin inhibition of IKKa and IKKh activity has been shown to be dependent on its inhibition of HSP90 ATPase activity and not necessarily due to decreases in IKKa and IKKh levels or interruption of the association between HSP90 and the IKKs (34). inhibited TNFa induction of both IKKa and IKKh activities by directly interacting with these kinases. These investigators also reported that the natural RAR agonist trans-retinoic acid, the RAR panantagonist, and AHPN/CD437 analogue (E)-7-[3-(1-adamantyl)-4-methoxyphenyl]-3-methylocta-2, 4,6-trienoic acid (CD2366) and the RARh, g-selective antagonist and AHPN/CD437 analogue 4-[6-(1-adamantyl)-7-methoxyethoxymethoxy-2-naphthalenyl]benzoic acid (CD2665), all of which were evaluated at 6 Amol/L had no or minimal inhibitory effect on IKK activity induced by TNFa and were unable to inhibit the proliferation or induce apoptosis of prostate or lung carcinoma cells (63) . In contrast to these studies, we have found that 3-Cl-AHPC stimulates IKK activity.
The introduction of a the 3-Cl ortho to the diaryl bonds resulted in the orientation of the 1-adamantyl group outside of the plane of the aromatic rings (64) ; this, in turn, resulted in the poor activation of RARg by 3-Cl-AHPC and its inability to disassociate RARg from its bound corepressors (64) . The mechanism by which 3-Cl-AHPC and CD437 induces apoptosis in a number of cell types remains undefined. Numerous pathways have been implicated and gene-targeting experiments have suggested that certain pathways play specific roles in CD437-mediated apoptosis in specific cell types (57) . These pathways include the mitogen-activated kinase pathway with the subsequent activation of c-Jun-NH 2 -kinase (JNK) and p38 kinases, and Research.
on July 27, 2017. © 2005 American Association for Cancer cancerres.aacrjournals.org Downloaded from inhibition of the MRP-I phosphatase, which plays a role in the inactivation of JNK (65) . Recently, Li et al. (66) and Lin et al. (67) have reported that exposure of cells to CD437/AHPN and 3-Cl-AHPC results in the translocation of the transcription factor TR3 from the nucleus to the mitochondria, with the binding of TR3 to Bcl-2 and the conversion of Bcl-2 to a proapoptotic molecule. There seems to be no role for the retinoid nuclear receptors in 3-Cl-AHPC-mediated apoptosis because 3-Cl-AHPC does not bind nor activate the retinoid X receptors and is an extremely poor activator of the RARs (20, 21) . We have found that 3-Cl-AHPC requires NF-nB activation for maximal apoptosis induction. NFnB activation in the presence of 3-Cl-AHPC results in the enhanced expression of a number of proapoptotic mediators and the inhibition of expression of a number of NF-nB-associated inhibitors of apoptosis. The exact mechanism by which 3-Cl-AHPC modulates the levels of these proteins remains to be discerned.
